Article
Integrative & Complementary Medicine
Lukas Israel, Gabriele Rotter, Ulrike Foerster-Ruhrmann, Josef Hummelsberger, Rainer Noegel, Andreas Michalsen, Tatjana Tissen-Diabate, Sylvia Binting, Thomas Reinhold, Miriam Ortiz, Benno Brinkhaus
Summary: Self-administered acupressure as a self-care technique shows potential benefits for patients with seasonal allergic rhinitis, improving disease-specific quality of life and reducing disease-related symptoms and medication intake. High-quality confirmatory studies are needed for further validation of these findings, including a sham-control group.
Article
Otorhinolaryngology
Marwa Abdelhafeez
Summary: The study evaluated the impact of perennial allergic rhinitis (PAR) on health-related quality of life (HRQL) and the effect of intra-nasal steroids (INS) on PAR symptoms. Results showed significant improvements in NRQLQ scores and domain scores after INS treatment, with a reduction in symptom severity and improvements in daytime sleepiness and sleep quality. Ins effectively improved PAR symptoms and overall QOL for patients.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
(2022)
Article
Allergy
Georgia Papapostolou, Hampus Kiotseridis, Kerstin Romberg, Aslog Dahl, Leif Bjermer, Magnus Lindgren, David Aronsson, Alf Tunsater, Ellen Tufvesson
Summary: The study found that cognitive function was impaired in grass pollen-allergic children during the pollen season, particularly in spatial working memory. The more severe the symptoms, the longer the reaction time in cognitive tests, and the quality of life was also impaired compared to non-allergic children. No differences were found in stress or inflammatory biomarkers between the groups.
PEDIATRIC ALLERGY AND IMMUNOLOGY
(2021)
Article
Medicine, General & Internal
Hahn Jin Jung, Young-Jun Chung, Young-Seok Choi, Phil Sang Chung, Ji-Hun Mo
Summary: Low-level laser therapy (LLLT) has shown significant efficacy in treating allergic rhinitis (AR) by improving symptom severity and quality of life. The clinical trial confirmed that the LLLT group performed better in reducing AR symptom severity and enhancing quality of life related to nasal symptoms.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Allergy
Alexander Karaulov, Natalia Nenasheva, Yury Smolkin, Aleksandr Maslakov, Luiz Lucio
Summary: The study demonstrates through a clinical trial that intranasal corticosteroid (TAA) has a significant improvement on the quality of life (QoL) of patients with perennial allergic rhinitis (PAR), especially in alleviating eye symptoms. There were no significant differences in efficacy between TAA and fluticasone propionate (FP).
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
(2022)
Article
Allergy
Bernardo Sousa-Pinto, Luis Filipe Azevedo, Marek Jutel, Ioana Agache, G. Walter Canonica, Wienczyslawa Czarlewski, Nikolaos G. Papadopoulos, Karl-Christian Bergmann, Philippe Devillier, Daniel Laune, Ludger Klimek, Aram Anto, Josep M. Anto, Patrik Eklund, Rute Almeida, Anna Bedbrook, Sinthia Bosnic-Anticevich, Helen A. Brough, Luisa Brussino, Victoria Cardona, Thomas Casale, Lorenzo Cecchi, Denis Charpin, Tomas Chivato, Elisio M. Costa, Alvaro A. Cruz, Stephanie Dramburg, Stephen R. Durham, Giulia De Feo, Roy Gerth van Wijk, Wystke J. Fokkens, Bilun Gemicioglu, Tari Haahtela, Maddalena Illario, Juan Carlos Ivancevich, Violeta Kvedariene, Piotr Kuna, Desiree E. Larenas-Linnemann, Michael Makris, Eve Mathieu-Dupas, Erik Melen, Mario Morais-Almeida, Ralph Moesges, Joaquim Mullol, Kari C. Nadeau, Nhan Pham-Thi, Robyn O'Hehir, Frederico S. Regateiro, Sietze Reitsma, Boleslaw Samolinski, Aziz Sheikh, Cristiana Stellato, Ana Todo-Bom, Peter Valentin Tomazic, Sanna Toppila-Salmi, Antonio Valero, Arunas Valiulis, Maria Teresa Ventura, Dana Wallace, Susan Waserman, Arzu Yorgancioglu, Govert Vries, Michiel Eerd, Petra Zieglmayer, Torsten Zuberbier, Oliver Pfaar, Joao Almeida Fonseca, Jean Bousquet
Summary: This study used real-life data to generate and validate combined symptom-medication scores (CSMSs). The cluster analysis-based CSMS showed the best performance, with medium-high validity, reliability, and accuracy.
Article
Immunology
Rui Tang, Shubin Lei, Liping Zhu, Yuzhen Lv, Hong Li
Summary: This study aimed to evaluate the preventative efficacy of omalizumab for seasonal allergic rhinoconjunctivitis (SARC) and explore its influencing factors. The retrospective analysis of patients' medical records found that pre-seasonal omalizumab treatment could significantly alleviate SARC-related symptoms and reduce medication use. The dosage and number of injections of omalizumab did not affect the preventative efficacy, with a single dose of 150mg achieving satisfactory outcomes.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Medicine, General & Internal
Edyta Krzych-Falta, Mira Lisiecka-Bielanowicz, Konrad Furmanczyk, Diana Dziewa-Dawidczyk, Joanna Strozek, Oksana Wojas, Filip Raciborski, Aneta Tomaszewska, Boleslaw Samolinski
Summary: The study found that only about 20% of patients diagnosed with perennial allergic rhinitis took preventive measures against dust mites. The most common preventive measures adopted were the use of mattress protectors and anti-dust-mite spray. Participants with higher education levels and residents of larger cities were more likely to take preventive measures.
ARCHIVES OF MEDICAL SCIENCE
(2022)
Article
Nutrition & Dietetics
Karin Ried, Nikolaj Travica, Yeah Paye, Avni Sali
Summary: This study aimed to assess the tolerability and efficacy of the probiotic formula NC-Seasonal-Biotic on hay fever symptoms. The results showed that in participants who completed the full study period, the active group experienced a significant reduction in symptoms, improved quality of life, and improved immune parameters. However, there were no significant differences in microbial changes between the groups.
FRONTIERS IN NUTRITION
(2022)
Article
Medicine, General & Internal
Velia Malizia, Giuliana Ferrante, Giovanna Cilluffo, Rosalia Gagliardo, Massimo Landi, Laura Montalbano, Salvatore Fasola, Mirella Profita, Amelia Licari, Gian Luigi Marseglia, Stefania La Grutta
Summary: This study identified three endotypes in children with seasonal allergic rhinitis (SAR) based on cytokine evaluation. The study also found differences in nasal pH, nasal nitric oxide, and neutrophil percentage among the different endotypes.
FRONTIERS IN MEDICINE
(2022)
Article
Allergy
Rene Maximiliano Gomez, Victor Hugo Croce, Mario Emilio Zernotti, Juan Carlos Muino
Summary: The study showed that active smokers with Allergic Rhinitis do not demonstrate impaired nasal-related quality of life or impact on atopic inflammatory parameters compared to non-smokers. Reduced levels of IL-33 in smokers could explain a lack of symptoms alerting smokers of the harmful consequences of smoking.
WORLD ALLERGY ORGANIZATION JOURNAL
(2021)
Article
Health Care Sciences & Services
Angela Rizzi, Giuseppe Parrinello, Eugenio De Corso, Laura Tricarico, Michele Centrone, Alessia Di Rienzo, Chiara Laface, Giulio Cesare Passali, Gabriella Cadoni, Riccardo Inchingolo, Gaetano Paludetti, Jacopo Galli, Eleonora Nucera
Summary: The study confirms the effectiveness of intranasal mometasone furoate in patients with NAR, with improvements in olfactory function and quality of life observed as therapeutic responses.
JOURNAL OF PERSONALIZED MEDICINE
(2022)
Article
Allergy
Jo A. Douglass, Caroline Lodge, Samantha Chan, Alice Doherty, Ju Ann Tan, Celina Jin, Alastair Stewart, Anne M. Southcott, Andrew Gillman, Joy Lee, Danny Csutoros, Liam Hannan, Laurence Ruane, Sara Barnes, Lou Irving, Nur-Shirin Harun, Phillipe Lachapelle, Kymble Spriggs, Michael Sutherland, Katharine See, Christine F. McDonald, Matthew Conron, Naghmeh Radhakrishna, Christopher Worsnop, Fay H. Johnston, Janet M. Davies, Vanessa Bryant, Linda Iles, David Ranson, Paresa Spanos, Don Vicendese, Adrian Lowe, Edward J. Newbigin, Philip Bardin, Shyamali Dharmage
Summary: This study found that low FEV1 value, high Asthma Control Questionnaire score, and elevated levels of RGP-sp IgE concentration, eosinophil counts, and fractional exhaled nitric oxide were associated with the risk of thunderstorm asthma among individuals with seasonal allergic rhinitis.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
(2022)
Article
Allergy
Tingting Ma, Hongtian Wang, Xueyan Wang
Summary: Omalizumab has been shown to be effective and safe in treating seasonal allergic rhinitis, improving patients' quality of life and symptoms in real-world settings.
JOURNAL OF ASTHMA AND ALLERGY
(2021)
Article
Immunology
Katti Blessi Sara, V Rupa, L. Jeyaseelan
Summary: This study evaluated the changes in olfaction and quality of life in patients with allergic rhinitis before and after medical therapy. The results showed significant improvement in olfaction and quality of life after treatment.
INDIAN JOURNAL OF MEDICAL RESEARCH
(2022)